Birchview Capital, LP Uni Qure N.V. Transaction History
Birchview Capital, LP
- $111 Million
- Q1 2025
A detailed history of Birchview Capital, LP transactions in Uni Qure N.V. stock. As of the latest transaction made, Birchview Capital, LP holds 88,697 shares of QURE stock, worth $1.34 Million. This represents 0.85% of its overall portfolio holdings.
Number of Shares
88,697
Previous 20,000
343.49%
Holding current value
$1.34 Million
Previous $353,000
166.29%
% of portfolio
0.85%
Previous 0.3%
Shares
2 transactions
Others Institutions Holding QURE
# of Institutions
178Shares Held
50.7MCall Options Held
2.13MPut Options Held
480K-
Vestal Point Capital, LP New York, NY4.79MShares$72.7 Million3.63% of portfolio
-
Rtw Investments, LP New York, NY4.27MShares$64.7 Million0.74% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.99MShares$60.5 Million3.32% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT2.76MShares$41.8 Million1.32% of portfolio
-
Abrdn PLC2.22MShares$33.6 Million0.05% of portfolio
About uniQure N.V.
- Ticker QURE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,729,100
- Market Cap $708M
- Description
- uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...